 <h1>Romidepsin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to romidepsin: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, romidepsin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking romidepsin:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>blurred vision</li>
<li>bone pain</li>
<li>chest pain</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>decreased urine output</li>
<li>difficulty with breathing</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>fast or irregular heartbeat</li>
<li>fever</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>hoarseness</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>joint pain, stiffness, or swelling</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>muscle spasms or twitching</li>
<li>nausea</li>
<li>numbness or tingling in the hands, fingertips, feet, or lips</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>seizures</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stomach cramps or pain</li>
<li>sweating</li>
<li>swelling of the face, ankles, feet, lower legs, or hands</li>
<li>swollen glands</li>
<li>tremor</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of romidepsin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Change in taste</li>
<li>constipation</li>
<li>cracks in the skin</li>
<li>diarrhea</li>
<li>itching</li>
<li>lack or loss of strength</li>
<li>loss of heat from the body</li>
<li>loss of taste</li>
<li>red, swollen skin</li>
<li>scaly skin</li>
<li>weight loss</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to romidepsin: intravenous powder for injection, intravenous solution</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (86%), vomiting (52%), constipation (40%), diarrhea (36%), abdominal pain (14%)</p>
<p><b>Common</b> (1% to 10%): Stomatitis<sup>[Ref]</sup></p><h3>General</h3><p>The most commonly reported adverse events included neutropenia, lymphopenia, thrombocytopenia, infections, nausea, fatigue, vomiting, anorexia, anemia, and ECG T-wave changes.  </p>
<p></p>
<p>The most commonly reported events leading to discontinuation included infection, fatigue, dyspnea, QT prolongation, and hypomagnesemia.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (72%), neutropenia (66%), leukopenia (46%), thrombocytopenia (65%), lymphopenia (57%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): ST-T wave changes on ECG (63%), hypotension (23%) </p>
<p><b>Common</b> (1% to 10%): Tachycardia, supraventricular arrhythmia, ventricular arrhythmia, edema, deep vein thrombosis, chest pain</p>
<p><b>Frequency not reported</b>: QT prolongation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (54%), hypocalcemia (52%), hyperglycemia (51%), hypoalbuminemia (48%), hyperuricemia (33%), hypomagnesemia (28%), hypermagnesemia (27%), hypophosphatemia (27%), hypokalemia (20%), weight loss (15%), hyponatremia (20%), </p>
<p><b>Common</b> (1% to 10%): Dehydration, hypoalbuminemia, hyperuricemia, tumor lysis syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dysgeusia (40%), headache (34%)</p>
<p><b>Common</b> (1% to 10%): Syncope, dizziness<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): AST elevations (28%), ALT elevations (22%) </p>
<p><b>Common</b> (1% to 10%): Hyperbilirubinemia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (31%), dermatitis/exfoliative dermatitis (27%)</p>
<p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infections (54%)</p>
<p><b>Common</b> (1% to 10%): Sepsis, upper respiratory infection, urinary tract infection, pneumonia, cellulitis, oral candidiasis, central line infection, catheter related infection</p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia/fatigue (77%), pyrexia (47%), chills (17%) </p>
<p><b>Common</b> (1% to 10%): Febrile neutropenia</p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (21%), dyspnea (21%) </p>
<p><b>Common</b> (1% to 10%): Pulmonary embolism, pneumonitis</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms, myalgia</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Istodax (romidepsin)." Gloucester Pharmaceuticals, Cambridge, MA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about romidepsin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>1 Review</li>
<li>Drug class: histone deacetylase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Romidepsin Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Istodax</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Peripheral T-cell Lymphoma</li>
<li>Cutaneous T-cell Lymphoma</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to romidepsin: intravenous powder for injection, intravenous solution</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (86%), vomiting (52%), constipation (40%), diarrhea (36%), abdominal pain (14%)</p><p><b>Common</b> (1% to 10%): Stomatitis<sup>[Ref]</sup></p><h3>General</h3><p>The most commonly reported adverse events included neutropenia, lymphopenia, thrombocytopenia, infections, nausea, fatigue, vomiting, anorexia, anemia, and ECG T-wave changes.  </p><p></p><p>The most commonly reported events leading to discontinuation included infection, fatigue, dyspnea, QT prolongation, and hypomagnesemia.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (72%), neutropenia (66%), leukopenia (46%), thrombocytopenia (65%), lymphopenia (57%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): ST-T wave changes on ECG (63%), hypotension (23%) </p><p><b>Common</b> (1% to 10%): Tachycardia, supraventricular arrhythmia, ventricular arrhythmia, edema, deep vein thrombosis, chest pain</p><p><b>Frequency not reported</b>: QT prolongation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (54%), hypocalcemia (52%), hyperglycemia (51%), hypoalbuminemia (48%), hyperuricemia (33%), hypomagnesemia (28%), hypermagnesemia (27%), hypophosphatemia (27%), hypokalemia (20%), weight loss (15%), hyponatremia (20%), </p><p><b>Common</b> (1% to 10%): Dehydration, hypoalbuminemia, hyperuricemia, tumor lysis syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dysgeusia (40%), headache (34%)</p><p><b>Common</b> (1% to 10%): Syncope, dizziness<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): AST elevations (28%), ALT elevations (22%) </p><p><b>Common</b> (1% to 10%): Hyperbilirubinemia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus (31%), dermatitis/exfoliative dermatitis (27%)</p><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity</p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infections (54%)</p><p><b>Common</b> (1% to 10%): Sepsis, upper respiratory infection, urinary tract infection, pneumonia, cellulitis, oral candidiasis, central line infection, catheter related infection</p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia/fatigue (77%), pyrexia (47%), chills (17%) </p><p><b>Common</b> (1% to 10%): Febrile neutropenia</p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Cough (21%), dyspnea (21%) </p><p><b>Common</b> (1% to 10%): Pulmonary embolism, pneumonitis</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms, myalgia</p><p id="ref_1">1. "Product Information. Istodax (romidepsin)." Gloucester Pharmaceuticals, Cambridge, MA. </p><h2>More about romidepsin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>1 Review</li>
<li>Drug class: histone deacetylase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Romidepsin Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Peripheral T-cell Lymphoma</li>
<li>Cutaneous T-cell Lymphoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>